Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013

Life Science R&D Big Data Leaders Forum

03 Dec 2013 - 05 Dec 2013 - Ramada Plaza Basel, Switzerland

Bookmark and Share

This 3 day forum is the “must attend” event for those senior decision-makers looking to make the shift towards big data and for those looking to improve their implementation of data-driven approaches for their specific departments.

The first day will feature several keynote presentations from C-Level thought leaders on big data in the R&D space and heads of major research institutions who are at the front-end of the big data challenge. They will be discussing the strategic drivers for big data and key implementation guidance on how to make best use of this approach.

Day 2&3 of the Forum will feature 3 specific streams depending on the phase of R&D that is most crucial for you:

-              Discovery & Translational Big Data Forum;

-              Clinical Data Management Forum;

-              Real-World & Health Outcomes Big Data Forum.

Discovery & Translational Big Data Forum will be focusing on important issues related to use of big data to support various functions within the drug discovery process, including better designing NMEs, re-engineering and re-initiating previously failed drug programs and will enable participants to make the most informed decisions possible on how to enhance the management and application of their discovery and translational data. Clinical Data Management Forum will explore a number of areas vital to the development of clinical data management (CDM) and present key issues in selecting and implementing a CDM system. Real-World & Health Outcomes Big Data Forum will discover how to best design observational studies to get most of the real world data generated, what are the new and innovative approaches to capture, store and manage as well as what is the role of evidence and health outcomes data in decision-making.

To request the full agenda please follow the link:

Erika Vavrovicova

Life science Big Data Leaders Forum

Tel: +421 232 660 382

Fax: +421 2 3301 0331


Further information
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos